The Investigational Link Between Gut Bacteria and Parkinson's: A New Disclosure by Indian Research

The relationship between the human brain and the digestive system has always been a subject of fascination for medical science. Recently, a groundbreaking study conducted in Kerala has shed new light on the profound link between gut-dwelling bacteria and Parkinson's disease. Parkinson's is a severe neurodegenerative disease of the brain (a condition where nerve cells gradually degenerate), which causes tremors, muscle stiffness, and slowness of movement in patients.

According to a study published in the international scientific journal 'npj Parkinson's Disease', researchers from the Cochin University of Science and Technology (CUSAT) and the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, have discovered that the gut bacteria of Parkinson's patients differ significantly compared to those of healthy individuals. This is the first study conducted on the Indian population that has linked the composition of the gut microbiome (an ecosystem of microorganisms) and its functional role to Parkinson's.

The Connection Between Parkinson's Disease and the Gut

Parkinson's disease begins when the neurons in the brain that produce dopamine (a neurotransmitter responsible for movement and physical control) slowly die. These cells degenerate in a region of the brain called the substantia nigra. However, scientists had long suspected that this disease does not originate solely in the brain, but may also stem from the gut through the continuous communication channel that exists between the intestine and the brain.

Research shows that years before the primary motor symptoms of Parkinson's, such as tremors, manifest, patients begin to exhibit constipation and other gastrointestinal non-motor symptoms. When a protein called alpha-synuclein misfolds and clumps together, it forms aggregates known as Lewy bodies. These aggregates accumulate in cells, trigger inflammation, and cause damage to nerve cells.

How Does the Gut Microbiome Work?

The human digestive system is home to trillions of bacteria, viruses, and fungi, which are collectively known as the gut microbiota. The colon alone harbours between 300 and 1,000 different species of microorganisms. In a healthy gut, beneficial bacteria produce short-chain fatty acids (SCFAs), which help maintain the integrity of the intestinal lining and regulate the immune system.

This study from Kerala utilized a metagenomic sequencing technique (the study of the genetic makeup of microorganisms) featuring 16S rRNA gene amplicon sequencing. The researchers discovered that Parkinson's patients had a higher proportion of inflammation-causing bacteria, while the abundance of beneficial SCFA-producing bacteria was significantly reduced.

This bacterial imbalance (dysbiosis) weakens the gut's protective barrier, allowing pro-inflammatory components and toxins to reach the brain via the bloodstream or the vagus nerve. According to Baby Chakrapani P. S., Director of the Nature Centre for Neuroscience at CUSAT, this change in bacterial abundance is directly linked to disease severity. These bacteria affect crucial brain chemicals such as dopamine, glutamate, and GABA (gamma-aminobutyric acid).

Study Statistics and Details

Funded by the Indian Council of Medical Research (ICMR), this study was conducted by CUSAT research associate Aneesa P. A. under the guidance of Prof. Chakrapani and Dr. Shyam Krishnan of SCTIMST. The study included 65 Parkinson's patients from SCTIMST's Comprehensive Care Center for Movement Disorders and 65 healthy individuals.

The healthy control group primarily consisted of the patients' spouses to ensure similar dietary habits, lifestyles, and environmental conditions for accurate comparison. The gut microbiome is profoundly affected by diet, age, gender, and genetics, which leads to varying results in studies from different regions of the world.

Parkinson's disease is generally more common in individuals over 60 years of age, affecting approximately 1% of the population. Early-onset PD refers to Parkinson's occurring in individuals under 50. Other physical symptoms of the disease include bradykinesia (slowness of movement), rigidity (muscle stiffness), and hypomimia (reduced facial expressions).

In addition, orthostatic hypotension (a drop in blood pressure upon standing) due to dysautonomia (dysfunction of the autonomic nervous system) is observed in 30% to 50% of patients. Sleep disorders are seen in 98% of patients and sensory deficits in 90%.

Importance for India and Future Directions

This research is highly promising for the Indian population. Since dietary habits and food patterns in India differ significantly from those in Western countries, understanding the bacterial profile of Indian patients is essential for early diagnosis of the disease. In the future, early-stage diagnosis of Parkinson's may become possible simply through a routine stool sample test.

Furthermore, new avenues for reducing the severity of Parkinson's or slowing its progression could open up through proper probiotics, dietary modifications, and targeted therapies to improve gut health. Currently, levodopa, MAO-B inhibitors, or deep brain stimulation only control symptoms, whereas gut-based treatments could target the root cause.

However, several questions still remain unanswered for scientists. Does bacterial imbalance in the gut cause Parkinson's, or do Parkinson's disease and its medications alter gut bacteria? Further research is needed to solve this 'chicken-and-egg' dilemma. Nevertheless, the gut-brain connection has heralded a new revolution in the treatment of neurological disorders.